Chardan Capital Reiterates Buy on Senti Biosciences, Maintains $6 Price Target
BenzingaAug 15, 2023 16:25
Senti Biosciences Analyst Ratings
BenzingaAug 15, 2023 16:23
Chardan Capital Maintains Buy on Senti Biosciences, Lowers Price Target to $6
BenzingaMay 12, 2023 01:08
Chardan Cuts Price Target on Senti Biosciences to $6 From $7, Keeps Buy Rating
MT NewswiresMay 11, 2023 18:22
Morgan Stanley Adjusts Price Target on Senti Biosciences to $2 From $3, Keeps Equalweight Rating
MT NewswiresMar 24, 2023 21:25
Morgan Stanley Maintains Equal-Weight on Senti Biosciences, Lowers Price Target to $2
BenzingaMar 24, 2023 20:46
Morgan Stanley Reaffirms Their Hold Rating on Senti Biosciences (SNTI)
TipRanksMar 24, 2023 18:31
Chardan Adjusts Price Target on Senti Biosciences to $7 From $8, Keeps Buy Rating
MT NewswiresMar 23, 2023 20:26
Chardan Capital Maintains Buy on Senti Biosciences, Lowers Price Target to $7
BenzingaMar 23, 2023 20:15
Chardan Adjusts Senti Biosciences' Price Target to $8 From $12, Keeps Buy Rating
MT NewswiresJan 30, 2023 19:57
Senti Biosciences Analyst Ratings
Benzinga Analyst RatingsJan 30, 2023 18:36
Senti Biosciences (SNTI) Receives a Buy From Bank of America Securities
TipRanksJan 30, 2023 16:00
Senti Biosciences (SNTI) Receives a Buy From Chardan Capital
TipRanksJan 28, 2023 02:58
Senti Biosciences Analyst Ratings
Benzinga Analyst RatingsJan 27, 2023 23:33
Morgan Stanley Maintains Equal-Weight on Senti Biosciences, Lowers Price Target to $3
Benzinga Real-time NewsJan 27, 2023 23:33
Senti Biosciences Analyst Ratings
Benzinga Analyst RatingsDec 16, 2022 23:12
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Senti Biosciences (SNTI)
TipRanksNov 11, 2022 21:10
No Data
No Data